Literature DB >> 15994779

Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells.

Anna Smed-Sörensen1, Karin Loré, Jayanand Vasudevan, Mark K Louder, Jan Andersson, John R Mascola, Anna-Lena Spetz, Richard A Koup.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) infection of dendritic cells (DCs) plays an important role in HIV-1 transmission and pathogenesis. Here, we studied the susceptibility of ex vivo-isolated CD11c+ myeloid DCs (MDCs) and CD123+ plasmacytoid DCs (PDCs) to HIV-1 infection and the function of these cells early after infection. Both DC subsets were susceptible to CCR5- and CXCR4-using HIV-1 isolates (BaL and IIIB, respectively). However, MDCs were more susceptible to HIV-1(BaL) infection than donor-matched PDCs. In addition, HIV-1(BaL) infected MDCs more efficiently than HIV-1(IIIB), whereas PDCs were equally susceptible to both isolates. While exposure to HIV-1 alone resulted in only weak maturation of DCs, Toll-like receptor 7/8 ligation induced full maturation in both infected and uninfected DCs. Maturation did not increase HIV-1 replication in infected DCs, and infected DCs retained their ability to produce tumor necrosis factor alpha after stimulation. Both HIV-1 isolates induced alpha interferon production exclusively in PDCs, irrespective of productive infection. In conclusion, PDCs and MDCs were susceptible to HIV-1 infection, but neither displayed functional defects as a consequence of infection. The difference in susceptibility of PDCs and MDCs to HIV-1 may have implications for HIV-1 transmission and DC-mediated transfer of HIV-1 to T cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994779      PMCID: PMC1168781          DOI: 10.1128/JVI.79.14.8861-8869.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Subpopulations of peripheral blood dendritic cells show differential susceptibility to infection with a lymphotropic strain of HIV-1.

Authors:  S Patterson; S P Robinson; N R English; S C Knight
Journal:  Immunol Lett       Date:  1999-03       Impact factor: 3.685

2.  In vitro HIV1 infection of CD34+ progenitor-derived dendritic/Langerhans cells at different stages of their differentiation in the presence of GM-CSF/TNF alpha.

Authors:  A S Charbonnier; B Verrier; C Jacquet; C Massacrier; M M Fiers; F Mallet; C Dezutter-Dambuyant; D Schmitt
Journal:  Res Virol       Date:  1996 Mar-Jun

Review 3.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

4.  Depletion in blood CD11c-positive dendritic cells from HIV-infected patients.

Authors:  F Grassi; A Hosmalin; D McIlroy; V Calvez; P Debré; B Autran
Journal:  AIDS       Date:  1999-05-07       Impact factor: 4.177

5.  Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay.

Authors:  J R Mascola; M K Louder; S R Surman; T C Vancott; X F Yu; J Bradac; K R Porter; K E Nelson; M Girard; J G McNeil; F E McCutchan; D L Birx; D S Burke
Journal:  AIDS Res Hum Retroviruses       Date:  1996-09-20       Impact factor: 2.205

6.  Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon.

Authors:  M Cella; D Jarrossay; F Facchetti; O Alebardi; H Nakajima; A Lanzavecchia; M Colonna
Journal:  Nat Med       Date:  1999-08       Impact factor: 53.440

7.  The susceptibility to X4 and R5 human immunodeficiency virus-1 strains of dendritic cells derived in vitro from CD34(+) hematopoietic progenitor cells is primarily determined by their maturation stage.

Authors:  B Canque; Y Bakri; S Camus; M Yagello; A Benjouad; J C Gluckman
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

8.  The effect of in vitro human immunodeficiency virus infection on dendritic-cell differentiation and function.

Authors:  B Canque; M Rosenzwajg; S Camus; M Yagello; M L Bonnet; M Guigon; J C Gluckman
Journal:  Blood       Date:  1996-12-01       Impact factor: 22.113

9.  HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation.

Authors:  Anna Smed-Sörensen; Karin Loré; Lilian Walther-Jallow; Jan Andersson; Anna-Lena Spetz
Journal:  Blood       Date:  2004-07-01       Impact factor: 22.113

10.  PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes.

Authors:  Tatsuyoshi Kawamura; Shannon E Bruse; Awet Abraha; Makoto Sugaya; Oliver Hartley; Robin E Offord; Eric J Arts; Peter A Zimmerman; Andrew Blauvelt; Shannon E Bruce
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more
  106 in total

1.  HIV-1 and pattern-recognition receptors: a marriage of convenience.

Authors:  Michel J Tremblay
Journal:  Nat Immunol       Date:  2010-05       Impact factor: 25.606

2.  Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression.

Authors:  Gang Peng; Teresa Greenwell-Wild; Salvador Nares; Wenwen Jin; Ke Jian Lei; Zoila G Rangel; Peter J Munson; Sharon M Wahl
Journal:  Blood       Date:  2007-03-19       Impact factor: 22.113

3.  Different Expression of Interferon-Stimulated Genes in Response to HIV-1 Infection in Dendritic Cells Based on Their Maturation State.

Authors:  Esther Calonge; Mercedes Bermejo; Francisco Diez-Fuertes; Isabelle Mangeot; Nuria González; Mayte Coiras; Laura Jiménez Tormo; Javier García-Perez; Nathalie Dereuddre-Bosquet; Roger Le Grand; José Alcamí
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

4.  Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses.

Authors:  Karin Loré; William C Adams; Menzo J E Havenga; Melissa L Precopio; Lennart Holterman; Jaap Goudsmit; Richard A Koup
Journal:  J Immunol       Date:  2007-08-01       Impact factor: 5.422

Review 5.  Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history.

Authors:  Patricia Fitzgerald-Bocarsly; Jihong Dai; Sukhwinder Singh
Journal:  Cytokine Growth Factor Rev       Date:  2008-01-11       Impact factor: 7.638

6.  HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells.

Authors:  Marta Catalfamo; Michele Di Mascio; Zonghui Hu; Sharat Srinivasula; Vishakha Thaker; Joseph Adelsberger; Adam Rupert; Michael Baseler; Yutaka Tagaya; Gregg Roby; Catherine Rehm; Dean Follmann; H Clifford Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-05       Impact factor: 11.205

7.  Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN.

Authors:  William C Adams; Emily Bond; Menzo J E Havenga; Lennart Holterman; Jaap Goudsmit; Gunilla B Karlsson Hedestam; Richard A Koup; Karin Loré
Journal:  J Gen Virol       Date:  2009-03-12       Impact factor: 3.891

8.  Type I interferon-dependent activation of NK cells by rAd28 or rAd35, but not rAd5, leads to loss of vector-insert expression.

Authors:  Matthew J Johnson; Niklas K Björkström; Constantinos Petrovas; Frank Liang; Jason G D Gall; Karin Loré; Richard A Koup
Journal:  Vaccine       Date:  2013-12-08       Impact factor: 3.641

9.  Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection.

Authors:  Heather Donaghy; Lidija Bosnjak; Andrew N Harman; Valerie Marsden; Stephen K Tyring; Tze-Chiang Meng; Anthony L Cunningham
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

Review 10.  Cellular reservoirs of HIV-1 and their role in viral persistence.

Authors:  Aikaterini Alexaki; Yujie Liu; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2008-09       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.